The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

EVM14, an mRNA cancer vaccine, received FDA clearance for investigational new drug application, advancing Everest's mRNA technology to global clinical trials. Preclinical studies showed EVM14 induces ...

Moving the drug toward human trials faces significant hurdles, primarily funding. Wang estimated the next phase will cost ...

Highlights from the oral presentation include: New efficacy findings consistently demonstrated rapid recovery and durable benefits of tanruprubart across muscle strength, mobility, and disability ...

today announced that the U.S. Food and Drug Administration (FDA) has cleared Altesa's new Investigational New Drug (IND) application for vapendavir for the treatment of rhinovirus infections in ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the next trade alert free. GBS is a neuromuscular emergency affecting ...

However, the US drug maker Eli Lilly's new experimental drug, lepodisiran, has shown promising results in reducing levels of ...